JPRN-jRCT1091220124已完成Unknown
[18F]-flutemetamol amyloid imaging along the continuum from normal cognitive status to Alzheimer's disease dementia.
Shizuo Hatashita0 个研究点目标入组 120 人开始时间: 2013年4月9日最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •AD, MCI and HC subjects undergo cognitive testing, [11C]-PIB PET and [18F]-flutemetamol PET. Informed consent is obtained.
排除标准
- •Other degenerative disease
研究者
相似试验
已完成
不适用
18F flutemetamol amyloid-beta PET imaging compared with 11CPIB across the spectrum of Alzheimer's diseaseAlzheimer's diseaseJPRN-UMIN000019573Shonan-Atsugi hospital200
已完成
2 期
Florbetapir F18 (18F-AV-45) amyloid positron emission tomography (PET) imaging in focal dementia syndromesFocal dementia syndromes - primary aphasiaMental and Behavioural DisordersMulti-infarct dementiaISRCTN57388990Avid Radiopharmaceuticals Inc. (USA)25
进行中（未招募）
1 期
oneFocal dementia syndromes - primary aphasiaMedDRA version: 14.1 Level: LLT Classification code 10012292 Term: Dementia of the Alzheimer's type NOS System Organ Class: 10029205 - Nervous system disordersEUCTR2010-023852-10-GBAvid Radiopharmaceuticals, Inc.23
已完成
不适用
Amyloid PET imaging study for dimenting disordersdementing disorderJPRN-UMIN000028758Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama20
招募中
不适用
The usefulness of flutemetamol for diagnostic imaging of neurogenerative diseaseJPRN-jRCTs051180214Itoh Yoshiaki100